First ten cancer treatments successfully performed with the CyberKnife® M6™ System using the new InCise™ 2 Multileaf Collimator

Munich, October 1st, 2015 - The European CyberKnife Center Munich (ECZM) announced today that they have successfully performed their first ten treatments with the CyberKnife® M6™ System using the new InCise™ 2 Multileaf Collimator (MLC). Recently developed and officially released for clinical usage, the MLC expands the versatility of the CyberKnife System, enabling clinicians to treat a broader range of tumors in size and shape than before with significantly reduced treatment times. With the adoption of the new InCise 2 MLC, the Munich CyberKnife Center continues to provide its patients with cutting-edge treatments.